Get the Stockscreener App
1.63
8.94%
-0.16
After Hours:
1.65
0.02
+1.23%
Glucotrack Inc stock is traded at $1.63, with a volume of 39,081.
It is down -8.94% in the last 24 hours and down -57.33% over the past month.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.
See More
Previous Close:
$1.79
Open:
$1.75
24h Volume:
39,081
Relative Volume:
0.13
Market Cap:
$1.65M
Revenue:
-
Net Income/Loss:
$-26.77M
P/E Ratio:
-0.00124
EPS:
-1316.2474
Net Cash Flow:
$-14.37M
1W Performance:
+5.16%
1M Performance:
-57.33%
6M Performance:
-71.70%
1Y Performance:
+207.32%
1-Day Range:
$1.60
$1.75
1-Week Range:
$1.5232
$1.8893
52-Week Range:
$0.0927
$15.90
Glucotrack Inc Stock (GCTK) Company Profile
Name
Glucotrack Inc
Sector
Industry
Phone
972 (8) 675-7878
Address
301 RT 17 NORTH, RUTHERFORD
Compare GCTK vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
1.63 | 1.81M | 0 | -26.77M | -14.37M | -1,316.25 |
|
ISRG
Intuitive Surgical Inc
|
478.60 | 176.19B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
177.81 | 51.41B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
78.55 | 39.00B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
44.59 | 37.48B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
245.73 | 37.82B | 5.40B | 1.49B | 1.78B | 10.12 |
Glucotrack Inc Stock (GCTK) Latest News
Chart Watch: Will GlucoTrack Inc benefit from geopolitical trendsMarket Risk Summary & Safe Investment Capital Preservation Plans - baoquankhu1.vn
GlucoTrack (NASDAQ:GCTK) and Varex Imaging (NASDAQ:VREX) Financial Survey - Defense World
Earnings Risk: Will GlucoTrack Inc benefit from current market trendsJuly 2025 EndofMonth & Fast Momentum Stock Entry Tips - baoquankhu1.vn
US Market Wrap: Will Voyager Acquisition Corp Equity Warrant benefit from current market trendsPortfolio Gains Summary & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Why Did Glucotrack Stock Surge 12% Pre-Market Today? - Stocktwits
Glucotrack secures three patents for implantable glucose monitor By Investing.com - Investing.com Nigeria
Glucotrack Announces 3 New Patents to Monitor Blood Glucose - Yahoo Finance
Glucotrack, Inc. (GCTK) stock: slides 30% despite trio of fresh USPTO patents for implantable CBGM platform - parameter.io
GlucoTrack Strengthens IP for Implantable Glucose Monitoring Platform - TipRanks
GlucoTrack’s Share Offering Spurs Market Activity - StocksToTrade
Glucotrack Stumbles Despite Winning Patent - Baystreet.ca
Glucotrack, Inc. Announces USPTO Approval for CBGM Patents - TradingView
Glucotrack secures three patents for implantable glucose monitor - Investing.com
Glucotrack stock soars after USPTO approves patents for glucose monitoring tech - Investing.com Nigeria
Glucotrack stock soars after USPTO approves patents for glucose monitoring tech By Investing.com - Investing.com South Africa
Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform - marketscreener.com
Implantable glucose sensor designed for 3 years, backed by new US patents - stocktitan.net
Published on: 2026-01-29 16:41:28 - baoquankhu1.vn
History Review: Can First BanCorp grow without external fundingJuly 2025 Closing Moves & Safe Entry Momentum Tips - baoquankhu1.vn
Market Review: Can WETH lead its sector in growthJuly 2025 Recap & Accurate Intraday Trade Tips - baoquankhu1.vn
Aug Update: Is Strategic Education Inc likely to announce a buybackJuly 2025 Patterns & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
GlucoTrack (NASDAQ:GCTK) Trading 2.9% Higher – Here’s What Happened - Defense World
Highs Report: Is GlucoTrack Inc impacted by rising ratesInflation Watch & Growth Oriented Trade Recommendations - baoquankhu1.vn
How GlucoTrack Inc. stock performs in rising dollar environmentEarnings Recap Report & Risk Managed Trade Strategies - bollywoodhelpline.com
Risk Analysis: Can GlucoTrack Inc beat the S P 5002025 Market Overview & Weekly High Return Stock Forecasts - baoquankhu1.vn
Will GlucoTrack Inc. stock reach all time highs in 20252025 Trade Ideas & Fast Exit/Entry Strategy Plans - ulpravda.ru
Why GlucoTrack Inc. stock remains undervaluedTrade Risk Summary & AI Powered Buy and Sell Recommendations - Улправда
Is GlucoTrack Inc. stock positioned well for digital economyWeekly Gains Report & Growth Focused Entry Reports - Улправда
Is GlucoTrack Inc. stock supported by strong fundamentalsJuly 2025 Patterns & AI Powered Trade Plan Recommendations - Улправда
Is GlucoTrack Inc. stock supported by innovation pipelineJuly 2025 Summary & AI Powered Market Entry Strategies - ulpravda.ru
ulpravda> 2026> Will GlucoTrack Inc. stock beat EPS estimatesCEO Change & Weekly High Conviction Trade Ideas - Улправда
Risk On: Is GlucoTrack Inc stock overvalued by current metricsJuly 2025 Retail & Community Consensus Stock Picks - moha.gov.vn
Levels Update: Can GlucoTrack Inc stock maintain operating marginsPortfolio Gains Report & Real-Time Market Trend Scan - moha.gov.vn
Glucotrack reports success in first human glucose monitor trial - MSN
GlucoTrack strengthens capital position with new private placement - TipRanks
Glucotrack Signs Multiple Material Agreements - TradingView — Track All Markets
Glucotrack announces pricing of private placement - Medical Buyer
Glucotrack raises $4 million in private placement to fund operations By Investing.com - Investing.com Nigeria
GlucoTrack Issues Investor Presentation Under Regulation FD - The Globe and Mail
Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor - The Globe and Mail
GlucoTrack stock falls after announcing $4 million private placement By Investing.com - Investing.com Australia
GlucoTrack stock falls after announcing $4 million private placement - Investing.com India
Glucotrack raises $4 million in private placement to fund operations - Investing.com
Diabetes tech firm lands $4M backing from single institutional investor - Stock Titan
Can GlucoTrack Inc stock weather global recession2025 Major Catalysts & Precise Swing Trade Entry Alerts - moha.gov.vn
Glucotrack Inc Stock (GCTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):